AzTrials
AzTrials

Postoperative Cognitive DysfunctionNCT04518839

The Comparison of Cognition, Depression and Anxiety, and Quality of Life After Hip Fracture Surgery Under General or Regional Anesthesia

An observational study of Postoperative Cognitive Dysfunction and Hip Fractures, run by University of Zagreb.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Postoperative cognitive dysfunction is a relatively common in elderly patients after hip surgery, but exact mechanism of its onset is still unclear as well as contributing factors. There is also increased incidence of depression and anxiety. Read more about this study

Who is it for?
Ages 60 years and older
How many people
140 participants
Where
No sites listed yet
Study dates
Aug 2020to Sep 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Adult, Older adult

Study population: Patients undergoing surgical treatment of hip fractures in Clinical Hospital Center Zagreb.

Who may be able to join

  • Patients intended for surgical treatment of hip fractures ≥ 60 years
  • Patients who are category ASA I to ASA III will be included in research
  • Sufficient cognitive ability
  • Only those patients who have agreed to be participants in the research and have signed the consent for participation and informed consent.

Who cannot join

  • Patients who refused to participate in the survey and who did not sign informed consent
  • Patients with ASA IV or more
  • Patients under 60 years
  • Severe psychiatric disorders involving the use of psychopharmaceuticals back three months
  • All patients who have other fractures in addition to hip fractures
  • Polytrauma
  • All patients scheduled for more than one surgical intervention during the procedure, or within the next 8 weeks
  • Patients who have been diagnosed with dementia, and / or are receiving anti-dementia drugs

Trial locations and contacts

No sites are listed yet.

Tea Fabijanić, MD contact

00385915698801

tea.fabijan@gmail.com

About this study

Official title: The Comparison of Cognitive Function, Symptoms of Depression and Anxiety, and Quality of Life in Patients After Hip Fracture Surgery Under General or Regional Anesthesia

Postoperative cognitive dysfunction is a relatively common in elderly patients after hip surgery, but exact mechanism of its onset is still unclear as well as contributing factors. There is also increased incidence of depression and anxiety. Both affect the recovery after surgery, slow it down and reduce the quality of life. Patients will be divided into two groups, operated under regional anaesthesia and operated under general anaesthesia, and monitored after surgery. Patients will be tested before and after surgery to evaluate postoperative cognitive deficits, depression and anxiety scale and health-related quality of life questionnaire.

Keywords
hip fracture surgery, regional anaesthesia, general anaesthesia, postoperative cognitive dysfunction, depression, anxiety, quality of life
Medical subject headings
Postoperative Cognitive Complications, Hip Fractures, Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04518839
Study groupRoleWhat they receive
Group with regional anaesthesiaNot described
Group with general anaesthesiaNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change in cognition

    MoCA scale (Montreal Cognitive Assessment), F-A-S test

    Measured: preoperatively/postoperative follow up 2 months

  2. change in anxiety and depression

    The HAD Scale (The Hospital Anxiety and Depression Scale)

    Measured: preoperatively/postoperative follow up 2 months

  3. change in quality of life

    EQ-5D-5L Questionnaire

    Measured: preoperatively/postoperative follow up 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Aug 2020
  2. Study startAug 2020 (estimated)
  3. Primary completionAug 2021 (estimated)
  4. Study completionSep 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
140 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04518839
Sponsor's protocol ID
643-03/20-07/33,380-130/134-20
Status last verified
Aug 2020
First submitted
14 Aug 2020
Last updated
19 Aug 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Postoperative Cognitive Dysfunction and Hip Fractures, run by University of Zagreb.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tea Fabijanić, MD (00385915698801, tea.fabijan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change in cognition (time frame: preoperatively/postoperative follow up 2 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in